Bellevue Life Sciences Ac... (BLAC)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
11.40
0.06 (0.53%)
At close: Jan 03, 2025, 9:00 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Net Income | 403.78K | -35.39K | -3.31K | -23.81K |
Depreciation & Amortization | n/a | n/a | n/a | n/a |
Stock-Based Compensation | n/a | n/a | n/a | n/a |
Other Working Capital | 517.35K | 31.15K | 2.85K | n/a |
Other Non-Cash Items | -2.78M | n/a | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.55M | 31.15K | 2.85K | n/a |
Operating Cash Flow | -818.77K | -4.24K | -461 | -23.81K |
Capital Expenditures | -4 | n/a | n/a | n/a |
Acquisitions | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -33.83M | n/a | n/a | n/a |
Investing Cash Flow | -33.83M | n/a | n/a | n/a |
Debt Repayment | -1.20M | 800.00K | 100.00K | n/a |
Common Stock Repurchased | -36.00M | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 7.77M | -676.02K | 10.00K | 86.47K |
Financial Cash Flow | 34.54M | 123.98K | -57.44K | 86.47K |
Net Cash Flow | -109.08K | 119.74K | -57.90K | 62.65K |
Free Cash Flow | -818.77K | -4.24K | -461 | -23.81K |